La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « A. D. Korczyn »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A. Criado < A. D. Korczyn < A. Danesi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000567 (2002) E. R. Brunt [Pays-Bas] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; J.-L. Montastruc [France] ; F. Stocchi [Italie]A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa
000608 (2000) O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada]A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa
000643 (1998) A. D. Korczyn [Israël] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; Werner Poewe [Autriche] ; O. Rascol [France] ; F. Stocchi [Italie]Ropinirole versus bromocriptine in the treatment of early Parkinson's disease : A 6-month interim report of a 3-year study
000644 (1998) O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; E. R. Brunt [Pays-Bas] ; A. D. Korczyn [Israël] ; Werner Poewe [Autriche] ; F. Stocchi [Italie]Ropinirole in the treatment of early Parkinson's disease : A 6-month interim report of a 5-year levodopa-controlled study

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Agonist
3Antiparkinson agent
3Chemotherapy
3Comparative study
3D2 Dopamine receptor
3Double blind study
3Early
3Human
3Parkinson disease
3Ropinirole
3Treatment
1Aged
1Aminoacid
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (therapeutic use)
1Benserazide
1Bromocriptine
1Decarboxylase
1Disease-Free Survival
1Dopa
1Dopamine agonist
1Double-Blind Method
1Drug Therapy, Combination
1Dyskinesia
1Dyskinesia, Drug-Induced (epidemiology)
1Dyskinesia, Drug-Induced (etiology)
1Dyskinesia, Drug-Induced (prevention & control)
1Enzyme inhibitor
1Female
1Humans
1Incidence
1Indoles (adverse effects)
1Indoles (therapeutic use)
1Levodopa
1Levodopa (adverse effects)
1Levodopa (therapeutic use)
1Male
1Middle Aged
1Multicenter study
1Parkinson Disease (drug therapy)
1Prevention
1Prospective Studies
1Randomization
1Risk Factors
1Treatment efficiency

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "A. D. Korczyn" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "A. D. Korczyn" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    A. D. Korczyn
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024